ArticleDrug safety2024

Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study.

Samantha B Shapiro et al.PubMed ↗Publisher ↗

No numbers read from the abstract.